Kevin S. Hamilton, Au.D., CCC-A

Kevin S. Hamilton

Au.D., CCC-A

Kevin is board certified by the American Speech-Language-Hearing Association (ASHA) and is licensed by the Oklahoma Board of Speech Language Pathology & Audiology (OBESPA) as well as the Texas Department of Licensing & Regulation (TDLR). Kevin developed an interest in the field while attending several medical missions overseas. He earned his undergraduate degree from Saint Louis University and went on to earn his doctorate from the University of North Texas. He subsequently completed his externship training in Audiology at Mercy Clinic Ear, Nose, and Throat.  Kevin’s research through the Center for Network Neuroscience at the University of North Texas is featured in Smart Biosensor Technology (2nd ed., 2019)., a book dedicated to the research, development, and application of biosensor technology. His work, which is published in the European Journal of Pharmacology, has been presented at the American Academy of Audiology National Conference and the Association for Research in Otolaryngology International Midwinter Meeting. Kevin joined Eastern Oklahoma ENT in 2017 and his clinical expertise is predominantly in auditory/vestibular diagnostics, electrophysiology, and aural rehabilitation. He currently maintains affiliation with and privileges to practice at Saint Francis Hospital, Ascension St. John Medical Center Tulsa and Ascension St. John Broken Arrow Hospital. 

Undergraduate Degree

Saint Louis University, Bachelor of Arts in Communication Sciences and Disorders, 2013

Graduate Degree

University of North Texas, Doctorate of Audiology, 2017

Internship/Externship

Audiology at Mercy Clinic Ear, Nose, and Throat in Springfield, MO

Professional Society Memberships

American Speech Language Hearing Association

Certifications and/or Affiliations

Certified by the American Speech-Language-Hearing Association

Publications and/or External Links

Hamilton, KS, Gopal KV, Moore EJ, Gross GW. (2017). Pharmacological response sensitization in nerve cell networks exposed to the antibiotic gentamicin. European Journal of Pharmacology, 794, 92-99. 
https://doi.org/10.1016/j.ejphar.2016.11.017